Business Context and Reporting Period
This Form 8-K is filed by Aerpio Pharmaceuticals, Inc. (trading symbol: ARPO) on July 24, 2019. The filing addresses a regulatory notice regarding the company's continued listing status on the Nasdaq Capital Market. Note: The request metadata references "Whitehawk Therapeutics, Inc.," but the filing text explicitly identifies the registrant as Aerpio Pharmaceuticals, Inc.
Key Financial Metrics
The filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on stock price compliance.
- Stock Price Deficiency: The common stock failed to maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days.
- Listing Status: The stock remains listed on the Nasdaq Capital Market pending compliance.
Material Changes
The primary material event is the receipt of a deficiency letter from the Nasdaq Listing Qualifications Department. This notification indicates a failure to satisfy Nasdaq Listing Rule 5550(a)(2) regarding the Minimum Bid Price Requirement. This is a change in regulatory standing rather than a change in operational financial performance.
Guidance, Outlook, and Risks
Compliance Period: The company has been granted an initial 180-day compliance period, ending on January 20, 2020, to regain compliance.
Path to Compliance: To cure the deficiency, the stock must close at $1.00 or more per share for a minimum of 10 consecutive business days within the compliance period.
Future Options: If the company fails to regain compliance by the deadline, it may be eligible for an additional 180-day period if it meets other listing standards (e.g., market value of publicly held shares). The company may consider a reverse stock split to address the price deficiency.
Risks: There is no assurance that the company will regain compliance, secure an additional compliance period, or successfully appeal a potential delisting determination. Failure to comply could result in delisting from the Nasdaq Capital Market.
Investor Verification Checklist
- Verify the current closing bid price of ARPO stock to assess proximity to the $1.00 threshold.
- Monitor for any announcements regarding a reverse stock split or other capital structure changes.
- Check for subsequent filings indicating whether the company has achieved 10 consecutive days of compliance or received a delisting notice.
- Confirm the company's market value of publicly held shares to determine eligibility for a second compliance period if needed.